Faber J, Friis T, Kirkegaard C, Lumholtz I B, Hansen J M, Siersbaek-Nielsen K, Skovsted L, Theilade P
Horm Metab Res. 1979 Jan;11(1):34-6. doi: 10.1055/s-0028-1092678.
Serum concentrations of T4, T3 and reverse T3 were studied in two hyperthyroid groups (n = 13 and 11), in a group of normals (n = 9) and in a group of L-T4 substituted patients (n = 7) with severe pretreatment hypothyroidism. Serum T4 did not change except in one of the hyperthyroid groups change to in which a slight decrease was found. In all groups a significant fall in serum T3 and a significant rise in serum reverse T3 were found. An expected increase in serum TSH in the normal and in the L-T4 substituted groups could not be demonstrated.
对两组甲状腺功能亢进患者(分别为13例和11例)、一组正常人(9例)以及一组曾接受过L-T4替代治疗且治疗前患有严重甲状腺功能减退症的患者(7例)的血清T4、T3及反T3浓度进行了研究。除一组甲状腺功能亢进患者出现轻微下降外,血清T4无变化。所有组均发现血清T3显著下降,血清反T3显著上升。正常组和L-T4替代组血清促甲状腺激素(TSH)未出现预期升高。